NGS-based RNA seq market was valued at US$ 1,414.59 million in 2018 and it is projected to reach US$ 7,984.90 million in 2027; it is expected to grow at a CAGR of 19.3% from 2018 to 2027
According to Straits Research, the global ngs sample preparation market size was valued at USD 1.41 Billion in 2021. It is projected to reach from USD XX Billion in 2022 to USD 5.38 Billion by 2030, growing at a CAGR of 14.32% during the forecast period (2022–2030).https://straitsresearch.com/report/ngs-sample-preparation-market/request-sample
According to Straits Research, the global ngs sample preparation market size was valued at USD 1.41 Billion in 2021. It is projected to reach from USD XX Billion in 2022 to USD 5.38 Billion by 2030, growing at a CAGR of 14.32% during the forecast period (2022–2030).https://straitsresearch.com/report/ngs-sample-preparation-market/request-sample
Next Generation Sequencing (NGS) Market is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.
Next Generation Sequencing (NGS) Market is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.
The Next Generation Sequencing Market is currently valued at USD 10.2 billion in the year 2022 a CAGR of 13.43% over the studied period 2022-2030. The next-generation sequencing (NGS) is a massively parallel sequencing technology that offers ultra-high throughput, scalability, and speed. The technology is used to determine the order of nucleotides in entire genomes or targeted regions of DNA or RNA. NGS has revolutionized the biological sciences, allowing labs to perform a wide variety of applications and study biological systems at a level never before possible. NGS has revolutionized the biological sciences, allowing labs to perform a wide variety of applications and study biological systems at a level never before possible.
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Oncology NGS Report by Material, Application, and Geography ? Global Forecast to 2023 is a professional and comprehensive research report on the world?s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).
Next Generation Sequencing (NGS) Market is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.
The global next generation sequencing (NGS) services market is estimated to garner a revenue of USD 18,000.0 Million by the end of 2033 by growing at a CAGR of ~20% over the forecast period, i.e., 2023 – 2033
Get FREE Sample of this Report at https://bit.ly/3qi724i Southeast Asia NGS In Agrigenomics Market report is an essential reference for who looks for detailed information on Southeast Asia NGS In Agrigenomics market.
[350 Pages Report] Next Generation Sequencing (NGS) Market categories the global market by Platforms (MiSeq, Illumina HiSeq, 454 Roche, Life Technologies Ion Proton/PGM, by Bioinformatics (RNA-Seq, ChIP-Seq), (SBS, SMRT & Pyrosequencing,), (Diagnostics, Personalized Medicine) & by Geography.
Global Market Insights Inc. Add New Report Global Next Generation Sequencing Market to its database which covers the market landscape and its growth prospects over the coming years.
iGATE Research has released a research report on “Global Next Generation Sequencing (NGS) Market (By Products - Consumables, Platforms, Services, Sequencing Services, Bioinformatics, Technology, Applications, End Users, Regions), Key Company Profiles - Forecast to 2025” Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=165 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
The NGS-based RNA seq market was valued at US$ 1,414.59 million in 2018 and it is projected to reach US$ 7,984.90 million in 2027; it is expected to grow at a CAGR of 19.3% from 2018 to 2027.
An outlook on PCR & NGS based diagnostic testing market growth is presented in this latest research report that reviews industry growth drivers, trends, regional factors & companies as well as provides forecasts for next few years.
On the basis of application, the global microRNA market is segmented into Clinical Diagnostics and Research. Research is the largest segment in global microRNA market, which is estimated to represent US$ 275.7 Mn, or 76.1% share of the total market in 2017 and US$ 525.6 Mn, or 78.8% by 2025 end, expanding at CAGR of 8.4% over the forecast period.
The report "European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020", analyzes and studies the major market drivers, restraints, opportunities, and challenges in Europe.
The global next generation sequencing market is geographically segmented into North America, Europe, Asia, and Rest of the World, with North America contributing the highest share, followed by Europe.
Next Generation Sequencing (NGS) Data Analysis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Sequencing (NGS) Data Analysis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Next-generation Sequencing (NGS) Market : Opportunities The effect of the driving variables is relied upon to defeat the impact of limitations. In addition, the usage of distributed computing in NGS for information the executives and undiscovered rising economies are required to give new market chances to next generation sequencing makers sooner rather than later.
Next Generation Sequencing (NGS) Market categories the global market by Platforms (MiSeq, Illumina HiSeq, 454 Roche, Life Technologies Ion Proton/PGM, by Bioinformatics (RNA-Seq, ChIP-Seq), & by Geography
[350 Pages Report] Next Generation Sequencing (NGS) Market categories the global market by Platforms (MiSeq, Illumina HiSeq, 454 Roche, Life Technologies Ion Proton/PGM, by Bioinformatics (RNA-Seq, ChIP-Seq), & by Geography
Global sequencing reagents market is expected to rise to an estimated value of USD 12.45 billion by 2026, registering a healthy CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the various innovations and advancement of techniques of sequencing.
Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AED market is currently dominated by UCB’s Keppra and GlaxoSmithKline’s Lamictal. Although both drugs have experienced significant generic erosion, they form the mainstay of epilepsy treatment in the nine markets and will continue to have significant market share during the forecast period. See Full Report @ bit.ly/1vM6jVN
“Market Snapshot: Mammography Systems 2006 to 2020 - Americas (US, Canada, Brazil, Mexico)” provides quantitative analysis of the two mammography systems market segments: full field mammography systems and film-screen mammography systems. See Full Report @ bit.ly/1tYAebh
The global temperature management market is estimated to grow at a CAGR of 2.4% from 2014 to 2019. Although mature markets such as the U.S., Germany, and U.K. hold larger shares in the temperature management market in 2014, the Asia-Pacific region is poised to grow at the highest CAGR of 3.4% in the next five years. The global temperature management market is highly competitive, with a large number of global and local players. See Full Report : http://bit.ly/ZXRBlm
Global Molecular Diagnostics Market is estimated to value over USD 12.6 billion by 2026 end and register a CAGR of over 8.9% during the forecast period 2019 to 2026.
Global Next Generation Sequencing (NGS) Market,By Product (Instruments (Hiseq series, Miseq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system), Consumables (Sample preparation consumables, Other), Services (Sequencing services, Data management services), by Application (Diagnostics, Drug Discovery , Biomarker Discovery , Precision Medicine , Agriculture & Animal Research), by End-user (Hospitals & Clinics, Research Centers and Academic & Government Institutes, and Pharmaceutical & Biotechnology Companies), by Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
The global NGS sample preparation market is projected to reach $3,279.3 million by 2026, growing from $1,468.9 million in 2020, at a CAGR of 14.24% during the forecast period 2021-2026.
For global markets, the Market analysis is supplied, along with information on development trends, competitive landscape analysis, and the state of development of major regions. According to straits research the Next-Generation Sequencing (NGS) Market Market will grow at a CAGR of 21.6% during the forecast period.
The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Download Sample at http://bit.ly/2zigGOc . Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic institutes are driving the growth of this market.
Geographically, the NGS-based RNA-seq market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Download Sample at http://bit.ly/2tTODzB . North America accounted for the largest share of the market in 2016, followed by Europe and Asia-Pasific. However, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022, owing to focus on R&D activities and the low cost of NGS products & services in this region.
Market Research Future has declared the expansion of the "Worldwide Biosurgery Market Research Report which gives Market Size, Shares and Forecasts till 2023.
The global genomics market is estimated to be valued at USD 46.2 billion in 2023 and is expected to exhibit a CAGR of 12.4% over the forecast period 2023-2028, as highlighted in a new report published by Coherent Market Insights.
COMPOSITES MARKET, 2021 TO 2030 MARKET ANALYSIS ? COMPETITOR TRACKING, OPPORTUNITIES AND STRATEGIES TO BOOST GROWTH- COVID-19 IMPACT AND RECOVERY, MARKET SHARE, INDUSTRY GROWTH, CSP MARKET RESEARCH
Market Research Future has declared the expansion of the "Worldwide Assisted Reproductive Technology Market Research Report which gives Market Size, Shares and Forecasts till 2023.
Market Research Future has declared the expansion of the "Worldwide Tumor Ablation Market Research Report which gives Market Size, Shares and Forecasts till 2023.
Market Research Future recently presented Global Blood Glucose Test Strip Market study with detailed review, portraying about the Product/Industry Scope and expounds market outlook and status to 2020.
The report gives detail analysis of the market structure along with forecast, market size & share, different segments and developing trends of the industry.
The global human identification market size was valued at $1.5 billion in 2022 and is projected to reach $3.7 billion by 2032, growing at a CAGR of 9.3% from 2023 to 2032.
Genomics is a traditional concept with traces of genome market traced back right from 1926 when a geneticist at the Jackson Laboratory Tom Roderick, coined the term genomics. In 1981, the 1st complete genome sequence of the human mitochondrion (16.6 kb), was registered. Then in 2003 the accomplishment of the Human Genome Project, sequencing of 3.2 billion base pairs of a DNA that make up the human genome, which took many years and cost hefty amounts of time and capital was completely sequenced, with every single human gene sequences were accessible in the public domain.
Next-generation sequencing (NGS) market is set to witness substantial growth through 2032 owing to the increasing use of the technology for diverse pharmaceutical & biopharmaceutical applications.
Next Generation Sequencing Market is expected to surpass US$ 30 Billion by the end of year 2025 with double digit CAGR during 2019-2025. Renub Research report titled “Next Generation Sequencing Market, Global NGS Forecast by End User, Type of Test, Disease, Informatics, Reimbursement, Company Analysis, Platform & Consumable" provides Next Generation Sequencing Market. Access full Research: https://www.renub.com/next-generation-sequencing-market-p.php
Global cancer profiling market size is expected to reach $20.35 Bn by 2028 at a rate of 11.0%, segmented as by technology, immunoassays, pcr (polymerized chain reaction), ngs (next-generation sequencing), microarrays, in-situ hybridization
Download Free Research Report PDF : http://bit.ly/2VyEeWH #PhotocatalyticCoatingsMarket #MarketAnalysis The Southeast Asia Photocatalytic Coatings market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024 Full report Url : http://bit.ly/2OJPP3P
Browse 141 market data Tables and 36 Figures spread through 193 Pages and in-depth TOC on "HLA Typing for Transplant Market by Technology (PCR (SSO, SSP, Real Time), Sequencing (NGS, Sanger)), Product (Instrument, Reagent, Software), Application (Chimerism, Antibody Screening), End User (Hospital, Diagnolab, Academia) - Global Forecast to 2025" View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/transplant-diagnostics-market-96374742.html
This report broadly segments the global next generation sequencing market into products & services, technology, application, and end user. The NGS market, by products & services is segmented into pre-sequencing products & services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics.
The global next generation sequencing market was valued at $13 billion in 2023, and is projected to reach $97.8 billion by 2035, growing at a CAGR of 18.3% from 2024 to 2035.